Parainflammation, chronic inflammation, and age-related macular degeneration

Research output: Contribution to journalArticle

99 Citations (Scopus)


Inflammation is an adaptive response of the immune system to noxious insults to maintain homeostasis and restore functionality. The retina is considered an immune-privileged tissue as a result of its unique anatomic and physiologic properties. During aging, the retina suffers from a low-grade chronic oxidative insult, which sustains for decades and increases in level with advancing age. As a result, the retinal innate-immune system, particularly microglia and the complement system, undergoes low levels of activation (parainflammation). In many cases, this parainflammatory response can maintain homeostasis in the healthy aging eye. However, in patients with age-related macular degeneration, this parainflammatory response becomes dysregulated and contributes to macular damage. Factors contributing to the dysregulation of age-related retinal parainflammation include genetic predisposition, environmental risk factors, and old age. Dysregulated parainflammation (chronic inflammation) in age-related macular degeneration damages the blood retina barrier, resulting in the breach of retinal-immune privilege, leading to the development of retinal lesions. This review discusses the basic principles of retinal innate-immune responses to endogenous chronic insults in normal aging and in age-related macular degeneration and explores the difference between beneficial parainflammation and the detrimental chronic inflammation in the context of age-related macular degeneration.

Original languageEnglish
Pages (from-to)713-725
Number of pages13
JournalJournal of Leukocyte Biology
Issue number5
Early online date20 Aug 2015
Publication statusPublished - 2015

Bibliographical note

© Society for Leukocyte Biology.

Fingerprint Dive into the research topics of 'Parainflammation, chronic inflammation, and age-related macular degeneration'. Together they form a unique fingerprint.

  • Cite this